Literature DB >> 8758054

Ivermectin-based control of onchocerciasis in northern Cameroon: individual factors influencing participation in community treatment.

J Gardon1, J M Macé, E Cadot, C Ogil, C Godin, M Boussinesq.   

Abstract

A study aimed at determining individual factors associated with participation in community treatment with ivermectin was conducted in a village hyperendemic for onchocerciasis in northern Cameroon. The respective influences of sex, age, place of residence, distance between the compound and the dosing point, compound size, and participation in treatment by authoritative individuals in the compound was evaluated using univariate and multivariate analysis. Participation in treatment was closely associated with the attitude of the compound heads. Participation of compound heads in treatment increased as the household size increased, and as the distance to the distribution point diminished. This may be explained by the fact that getting information on health programmes is easier in large households whose members are involved in various social activities, and in compounds located near the village centre. Staff involved in health education should take this issue into account, and try to ensure circulation of information particularly to those living in small or remote compounds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8758054     DOI: 10.1016/s0035-9203(96)90219-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  Community mass treatment with azithromycin for trachoma: Factors associated with change in participation of children from the first to the second round.

Authors:  Elizabeth N Ssemanda; Harran Mkocha; Joshua Levens; Beatriz Munoz; Sheila K West
Journal:  Clin Epidemiol Glob Health       Date:  2015-04

2.  Mass treatment with azithromycin for trachoma control: participation clusters in households.

Authors:  Elizabeth N Ssemanda; Beatriz Munoz; Emma M Harding-Esch; Tansy Edwards; Harran Mkocha; Robin L Bailey; Ansumana Sillah; Dianne Stare; David C W Mabey; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

Review 3.  The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination.

Authors:  Jo-An Atkinson; Andrew Vallely; Lisa Fitzgerald; Maxine Whittaker; Marcel Tanner
Journal:  Malar J       Date:  2011-08-04       Impact factor: 2.979

4.  Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.

Authors:  Nancy J Haselow; Julie Akame; Cyrille Evini; Serge Akongo
Journal:  Filaria J       Date:  2003-10-24

5.  Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial.

Authors:  Joseph Kamgno; Patrick Nguipdop-Djomo; Raceline Gounoue; Mathurin Téjiokem; Annette C Kuesel
Journal:  PLoS Negl Trop Dis       Date:  2016-03-11

6.  Patterns of individual non-treatment during multiple rounds of mass drug administration for control of soil-transmitted helminths in the TUMIKIA trial, Kenya: a secondary longitudinal analysis.

Authors:  William E Oswald; Stella Kepha; Katherine E Halliday; Carlos Mcharo; Th'uva Safari; Stefan Witek-McManus; Robert J Hardwick; Elizabeth Allen; Sultani H Matendechero; Simon J Brooker; Sammy M Njenga; Charles S Mwandawiro; Roy M Anderson; Rachel L Pullan
Journal:  Lancet Glob Health       Date:  2020-11       Impact factor: 26.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.